Clinical trials
Phase 3 Hodgkin Disease trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 3 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2019 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Oncology Group | 2 |
| European Organisation for Research and Treatment of Cancer - EORTC | 2 |
| NCIC Clinical Trials Group | 2 |
| Eastern Cooperative Oncology Group | 1 |
| National Cancer Institute (NCI) | 1 |
| Novartis Pharmaceuticals | 1 |
| Radiation Therapy Oncology Group | 1 |
| Takeda | 1 |
| The Canadian Blood and Marrow Transplant Group | 1 |
| University College, London | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hodgkin Disease | 13 |
| Lymphoma | 7 |
| Burkitt Lymphoma | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 |
| Lymphoma, B-Cell, Marginal Zone | 4 |
| Lymphoma, Follicular | 4 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Lymphoma, Large-Cell, Immunoblastic | 4 |
| Lymphoma, Mantle-Cell | 4 |
| Lymphoma, Non-Hodgkin | 4 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.